Journal article : Comment
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Publisher copy:
- 10.1016/s2352-3026(21)00110-1
Authors
+ NIHR Biomedical Research Centre at The Royal Marsden and the ICR
More from this funder
- Funder identifier:
- https://ror.org/014ktry78
- Publisher:
- Elsevier
- Journal:
- Lancet Haematology More from this journal
- Volume:
- 8
- Issue:
- 6
- Pages:
- e389-e392
- Place of publication:
- England
- Publication date:
- 2021-04-19
- Acceptance date:
- 2021-04-09
- DOI:
- EISSN:
-
2352-3026
- ISSN:
-
2352-3026
- Pmid:
-
33887255
- Language:
-
English
- Subtype:
-
Comment
- Pubs id:
-
2351706
- UUID:
-
uuid_bf41a52c-89e5-452f-8351-f795f802ce7d
- Local pid:
-
pubs:2351706
- Source identifiers:
-
W3153656426
- Deposit date:
-
2025-12-23
- ARK identifier:
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2021
- Rights statement:
- © 2021 Elsevier Ltd. All rights reserved.
If you are the owner of this record, you can report an update to it here: Report update to this record